Evidence map›Paper›PMID 14578173›Full record

ArticleThe American journal of pathology2003

Susceptibility to anthrax lethal toxin is controlled by three linked quantitative trait loci.

Ryan D McAllister, Yogendra Singh, Wendy D du Bois, Michael Potter, Thomas Boehm, Nathan D Meeker, Parley D Fillmore, Lisa M Anderson, Matthew E Poynter, Cory Teuscher

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The American journal of pathology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Anthrax and the inflammasome.Microbes and infection · 2012
    Review
  4. Cellular and physiological effects of anthrax exotoxin and its relevance to disease.Frontiers in cellular and infection microbiology · 2012
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Cisplatin inhibition of anthrax lethal toxin.Antimicrobial agents and chemotherapy · 2006
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Ryan D McAllisterDepartment of Microbiology, University of Illinois, Urbana, IL, USA.
Yogendra Singh
Wendy D du Bois
Michael Potter
Thomas Boehm
Nathan D Meeker
Parley D Fillmore
Lisa M Anderson
Matthew E Poynter
Cory Teuscher
University of Illinois Urbana-Champaign · USUniversity of Vermont · USNational Institutes of Health · USInstitute of Genomics and Integrative Biology · INPediatrics and Genetics · US

Funding

IMMUNOREGULATORY LOCI IN ORGAN SPECIFIC AUTOIMMUNITYR01AI045105 · NIAID · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI TEUSCHER, CORY · 1999 to 2001
$338k
NIAID NIH HHS AI 45105
6 · The paper itself

Abstract

Anthrax lethal toxin (LT) is the principal virulence factor associated with lethal pathologies following infection with Bacillus anthracis. Macrophages are the primary effector cells mediating lethality since macrophage-depleted mice are resistant to LT challenge. Recently, Ltxs1, the gene controlling differential susceptibility of murine macrophages to cytolysis following in vitro exposure to LT, was identified as Kif1c. To directly assess the in vivo role of Kif1c alleles in mortality, we studied a panel of interval-specific recombinant congenic lines carrying various segments of central chromosome 11 derived from LT-resistant DBA/2 mice on the LT-susceptible BALB/c background. The results of this study reveal that mortality is controlled by three linked quantitative trait loci (QTL): Ltxs1/Kif1c (42-43 cM), Ltxs2 (35-37 cM), and Ltxs3 (45-47 cM). The Ltxs3 interval encompasses Nos2, which is an attractive candidate gene for Ltxs3. In this regard, we demonstrate that selective, pharmacologically based inhibition of Nos2 activity in vivo partially overrides genetic resistance to LT and that Nos2 expression as determined by reverse transcription-polymerase chain reaction differs significantly between DBA/2 and BALB/c macrophages. Additionally, to recapitulate dominant resistance to mortality as seen in (BALB/c x DBA/2) F(1) hybrids, DBA/2 alleles are required at all three QTL.

Indexed as

Antigens, BacterialGenetic Predisposition to DiseaseAnimalsBacterial ToxinsFemaleGenotypeKinesinsMaleMiceMice, CongenicNitric Oxide SynthaseNitric Oxide Synthase Type IIQuantitative Trait LociReverse Transcriptase Polymerase Chain ReactionSpecies Specificityanthrax toxinAntigens, BacterialBacterial ToxinsKif1c protein, mouseKinesinsNitric Oxide SynthaseNitric Oxide Synthase Type IINos2 protein, mouse

Identifiers

PMID14578173
PMCPMC1892420
OpenAlexW2143379693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.